A New Dawn for Strategy


The persisting uncertainty has prompted business leaders to rethink how they do strategy. Community Members tell Emma Carroll how they are ensuring success in the short, medium and long term.

Featuring commentary from:

Justin Ash, CEO, Spire Healthcare: You have a big funnel coming in, you’re prepared to back things that may or may not work and you allocate capital to ideas.

Matthew Blagg, CEO, Criticaleye: Longer-term thinking is a muscle, and if you don’t use it then it wastes away.

Deborah Frost, CEO, Personal Group: We've become more focused on developing what isn't ‘business as usual’. We're being really clear about what other things we should be paying attention to as a senior leadership team.

Stephen Harrison, CEO, Forterra: People get hung up on the word strategy, but probably the more important word at the moment is agility.

Share this with your Community


Contributors
Deborah Frost
Chair UK
Mercer
Justin Ash
CEO
Spire Healthcare Group Plc
Matthew Blagg
CEO
Criticaleye
Stephen Harrison
Chair
Epwin Group Plc


Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Click here to download this insight

BLOG | What Sets World-Class CEOs Apart in Uncertain Times?

If you're a CEO today, you’re likely feeling the pressure to be a technologist, a geopolitical expert and a visionary all at once. Markets are shifting rapidly, the operating...


Click here to download this insight

Health and Wellbeing at Work

The CIPD’s 2025 Health and Wellbeing at Work report, supported by Criticaleye CPO Retreat 2026 Partner Simplyhealth, examines health, wellbeing and attendance trends and challenges. Now in its 24th edition, t...


Inspiring Leaders Podcast: Sally Bridgeland, Chair, Development Bank of Wales and Keith Cochrane, Chair, Schenck Process Group, on Risk in the Boardroom

In this episode, Sally Bridgeland, Chair, Development Bank of Wales, Nest Invest and BelleVie Care and Keith Cochrane, Chair, Schenck Process Group talk about what risks will be on the Board agenda this yea...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 224




Lightsource bp NATS Rolls-Royce GlaxoSmithKline plc Drax Group plc LACE Partners Legal & General Canaccord Genuity Group Inc Worldpay NatWest Group Mayborn Group E.ON UK Aldermore Group AlixPartners London Stock Exchange Group Hitachi Solutions British Land